pivalyloxymethyl butyrate has been researched along with Leukemia, Myeloid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batova, A; Diccianni, MB; Nudelman, A; Rephaeli, A; Shao, LE; Tanaka, T; Yu, AL; Yu, J | 1 |
| Honma, Y; Kasukabe, T; Rephaeli, A | 1 |
| Aviram, A; Nudelman, A; Rabizadeh, E; Rephaeli, A; Shaklai, M; Zhuk, R; Zimra, Y | 1 |
3 other study(ies) available for pivalyloxymethyl butyrate and Leukemia, Myeloid
| Article | Year |
|---|---|
The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.
Topics: Acetylation; Acute Disease; Apoptosis; Butyrates; Cell Division; Child; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Genes, MDR; Hematopoietic Stem Cells; Histone Deacetylase Inhibitors; Histones; HL-60 Cells; Humans; Infant; Inhibitory Concentration 50; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Neoplasm Proteins; Neoplasms; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Processing, Post-Translational; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2002 |
An anti-cancer derivative of butyric acid (pivalyloxmethyl buterate) and daunorubicin cooperatively prolong survival of mice inoculated with monocytic leukaemia cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Butyrates; Cell Differentiation; Cell Division; Daunorubicin; Drug Screening Assays, Antitumor; Female; Humans; Leukemia, Myeloid; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Survival Analysis; Tumor Cells, Cultured | 1997 |
Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis.
Topics: Animals; Antineoplastic Agents; Butyrates; Carbon Radioisotopes; Esterases; HL-60 Cells; Humans; Hydrolysis; Leukemia, Myeloid; Mice; Prodrugs; Time Factors; Tumor Cells, Cultured | 2000 |